ATE488501T1 - Cyclopropylpiperidinglycin-transporter-inhibito - Google Patents
Cyclopropylpiperidinglycin-transporter-inhibitoInfo
- Publication number
- ATE488501T1 ATE488501T1 AT05801197T AT05801197T ATE488501T1 AT E488501 T1 ATE488501 T1 AT E488501T1 AT 05801197 T AT05801197 T AT 05801197T AT 05801197 T AT05801197 T AT 05801197T AT E488501 T1 ATE488501 T1 AT E488501T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclopropylpiperidinglycine
- inhibito
- transporter
- glycine transporter
- transporter glyt1
- Prior art date
Links
- 102000010726 Glycine Plasma Membrane Transport Proteins Human genes 0.000 abstract 2
- 108010063380 Glycine Plasma Membrane Transport Proteins Proteins 0.000 abstract 2
- 102100023145 Sodium- and chloride-dependent glycine transporter 1 Human genes 0.000 abstract 2
- 101710083171 Sodium- and chloride-dependent glycine transporter 1 Proteins 0.000 abstract 2
- JUBXTBVKELTJEX-UHFFFAOYSA-N 1-cyclopropylpiperidine Chemical class C1CC1N1CCCCC1 JUBXTBVKELTJEX-UHFFFAOYSA-N 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 230000024587 synaptic transmission, glutamatergic Effects 0.000 abstract 1
- 230000027682 synaptic transmission, glycinergic Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61494204P | 2004-09-30 | 2004-09-30 | |
| PCT/US2005/034301 WO2006039221A2 (en) | 2004-09-30 | 2005-09-26 | Cyclopropyl piperidine glycine transporter inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE488501T1 true ATE488501T1 (de) | 2010-12-15 |
Family
ID=36142986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05801197T ATE488501T1 (de) | 2004-09-30 | 2005-09-26 | Cyclopropylpiperidinglycin-transporter-inhibito |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7776886B2 (de) |
| EP (1) | EP1797035B1 (de) |
| JP (1) | JP4646984B2 (de) |
| KR (1) | KR20070058565A (de) |
| CN (1) | CN101031547A (de) |
| AT (1) | ATE488501T1 (de) |
| AU (1) | AU2005292323B2 (de) |
| BR (1) | BRPI0515954A (de) |
| CA (1) | CA2581582C (de) |
| DE (1) | DE602005024838D1 (de) |
| IL (1) | IL182253A0 (de) |
| MX (1) | MX2007003816A (de) |
| NO (1) | NO20072208L (de) |
| RU (1) | RU2387644C2 (de) |
| WO (1) | WO2006039221A2 (de) |
| ZA (1) | ZA200701612B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1684759A4 (de) * | 2003-11-12 | 2009-06-10 | Merck & Co Inc | 4-phenyl-piperidinsulfonyl-glycin-transporter-hemmer |
| AU2005228133B2 (en) * | 2004-03-24 | 2011-09-08 | Merck Sharp & Dohme Corp. | Heteroaryl piperidine glycine transporter inhibitors |
| AU2005243192A1 (en) * | 2004-04-29 | 2005-11-24 | Merck & Co., Inc. | Azetidine glycine transporter inhibitors |
| WO2005107469A2 (en) * | 2004-05-05 | 2005-11-17 | Merck & Co., Inc. | Morpholinyl piperidine glycine transporter inhibitors |
| WO2006067529A1 (en) * | 2004-12-21 | 2006-06-29 | Merck Sharp & Dohme Limited | Piperidine and azetidine derivatives as glyt1 inhibitors |
| PE20061490A1 (es) * | 2005-06-06 | 2007-02-09 | Merck Sharp & Dohme | Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1 |
| AU2006258842B2 (en) | 2005-06-13 | 2011-09-15 | Merck Sharp & Dohme Limited | Therapeutic agents |
| AU2006309050B2 (en) | 2005-10-28 | 2012-08-16 | Merck Sharp & Dohme Corp. | Piperidine glycine transporter inhibitors |
| EP2403337A4 (de) * | 2009-03-03 | 2012-08-15 | Univ Vanderbilt | Alkylsulfonyl-2,3-dihydrospiro[inden-1,4'-piperidin]-analoge als glyt1-hemmer, verfahren zu ihrer herstellung sowie ihre verwendung zur behandlung psychiatrischer erkrankungen |
| EP3134406A1 (de) | 2014-04-24 | 2017-03-01 | Dart Neuroscience (Cayman) Ltd | Substituierte 2,4,5,6-tetrahydropyrrolo [ 3,4-c ] pyrazol-und 4,5,6,7-tetrahydro-2 h-pyrazolo [ 4,3-c ] pyridinverbindungen als glyt1-inhibitoren |
| EP3215500A1 (de) | 2014-11-05 | 2017-09-13 | Dart NeuroScience (Cayman) Ltd. | Substituierte azetidinylverbindungen als glyt1-inhibitoren |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5532237A (en) | 1995-02-15 | 1996-07-02 | Merck Frosst Canada, Inc. | Indole derivatives with affinity for the cannabinoid receptor |
| US6303637B1 (en) * | 1998-10-30 | 2001-10-16 | Merck & Co., Inc. | Heterocyclic potassium channel inhibitors |
| RU2002126554A (ru) * | 2000-03-06 | 2004-03-20 | Акадиа Фармасьютикалз, Инк. (Us) | Азациклические соединения для применения при лечении опосредованных серотонином заболеваний |
| WO2001070708A1 (en) * | 2000-03-23 | 2001-09-27 | Merck & Co., Inc. | Substituted piperidines as melanocortin receptor agonists |
| US7507767B2 (en) | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
| CN100567266C (zh) * | 2001-11-14 | 2009-12-09 | 先灵公司 | 类大麻苷受体配体 |
| GB0130696D0 (en) | 2001-12-21 | 2002-02-06 | Smithkline Beecham Plc | Chemical Compounds |
| TW200403058A (en) | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
| EP1684759A4 (de) | 2003-11-12 | 2009-06-10 | Merck & Co Inc | 4-phenyl-piperidinsulfonyl-glycin-transporter-hemmer |
| AU2005228133B2 (en) * | 2004-03-24 | 2011-09-08 | Merck Sharp & Dohme Corp. | Heteroaryl piperidine glycine transporter inhibitors |
| AU2005243192A1 (en) * | 2004-04-29 | 2005-11-24 | Merck & Co., Inc. | Azetidine glycine transporter inhibitors |
| WO2005107469A2 (en) | 2004-05-05 | 2005-11-17 | Merck & Co., Inc. | Morpholinyl piperidine glycine transporter inhibitors |
| WO2006067529A1 (en) | 2004-12-21 | 2006-06-29 | Merck Sharp & Dohme Limited | Piperidine and azetidine derivatives as glyt1 inhibitors |
| PE20061490A1 (es) * | 2005-06-06 | 2007-02-09 | Merck Sharp & Dohme | Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1 |
| US7834031B2 (en) | 2005-09-29 | 2010-11-16 | Merck Sharp & Dohme Corp. | Radiolabeled glycine transporter inhibitors |
| AU2006309050B2 (en) | 2005-10-28 | 2012-08-16 | Merck Sharp & Dohme Corp. | Piperidine glycine transporter inhibitors |
-
2005
- 2005-09-26 AU AU2005292323A patent/AU2005292323B2/en not_active Ceased
- 2005-09-26 DE DE602005024838T patent/DE602005024838D1/de not_active Expired - Lifetime
- 2005-09-26 KR KR1020077007362A patent/KR20070058565A/ko not_active Withdrawn
- 2005-09-26 JP JP2007534679A patent/JP4646984B2/ja not_active Expired - Fee Related
- 2005-09-26 EP EP05801197A patent/EP1797035B1/de not_active Expired - Lifetime
- 2005-09-26 CA CA2581582A patent/CA2581582C/en not_active Expired - Lifetime
- 2005-09-26 US US11/664,190 patent/US7776886B2/en active Active
- 2005-09-26 AT AT05801197T patent/ATE488501T1/de not_active IP Right Cessation
- 2005-09-26 CN CNA2005800331179A patent/CN101031547A/zh active Pending
- 2005-09-26 MX MX2007003816A patent/MX2007003816A/es active IP Right Grant
- 2005-09-26 WO PCT/US2005/034301 patent/WO2006039221A2/en not_active Ceased
- 2005-09-26 RU RU2007116165/04A patent/RU2387644C2/ru not_active IP Right Cessation
- 2005-09-26 BR BRPI0515954-7A patent/BRPI0515954A/pt not_active IP Right Cessation
-
2007
- 2007-02-23 ZA ZA200701612A patent/ZA200701612B/xx unknown
- 2007-03-27 IL IL182253A patent/IL182253A0/en unknown
- 2007-04-27 NO NO20072208A patent/NO20072208L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20080108663A1 (en) | 2008-05-08 |
| JP2008514705A (ja) | 2008-05-08 |
| RU2387644C2 (ru) | 2010-04-27 |
| NO20072208L (no) | 2007-04-27 |
| MX2007003816A (es) | 2007-04-24 |
| JP4646984B2 (ja) | 2011-03-09 |
| EP1797035A2 (de) | 2007-06-20 |
| WO2006039221A3 (en) | 2006-09-08 |
| CA2581582C (en) | 2010-07-20 |
| US7776886B2 (en) | 2010-08-17 |
| AU2005292323A1 (en) | 2006-04-13 |
| DE602005024838D1 (en) | 2010-12-30 |
| ZA200701612B (en) | 2009-05-27 |
| EP1797035A4 (de) | 2009-08-05 |
| IL182253A0 (en) | 2007-09-20 |
| WO2006039221A2 (en) | 2006-04-13 |
| CA2581582A1 (en) | 2006-04-13 |
| AU2005292323B2 (en) | 2011-06-09 |
| EP1797035B1 (de) | 2010-11-17 |
| CN101031547A (zh) | 2007-09-05 |
| RU2007116165A (ru) | 2008-11-10 |
| BRPI0515954A (pt) | 2008-08-12 |
| KR20070058565A (ko) | 2007-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005046601A3 (en) | 4-phenyl piperdine sulfonyl glycine transporter inhibitors | |
| NO20072208L (no) | Syklopropylpiperidinglysintransportorinhibitorer. | |
| WO2005094514A3 (en) | Heteroaryl piperidine glycine transporter inhibitors | |
| SG151327A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| ATE549330T1 (de) | Zur behandlung von erkrankungen des zns geeignete derivate des 4-piperazin-1-yl-4-benzoäbüthiophens | |
| EA200900098A1 (ru) | Пептидные соединения для лечения расстройств, связанных с повышенной возбудимостью, и болезней, связанных с дисфункцией ионных каналов | |
| DE602007008434D1 (de) | Rezeptoren | |
| CY1112238T1 (el) | Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων | |
| CR9347A (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| MA31451B1 (fr) | Antagonistes des recepteurs de l'orexine de pyridyl piperidine. | |
| WO2005063766A3 (en) | Bicyclic heterocyclic p-38 kinase inhibitors | |
| EA201170624A1 (ru) | Изоникотинамидные антагонисты рецепторов орексинов | |
| NO20074431L (no) | Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer | |
| CY1106902T1 (el) | Κρυσταλλικη μορφη μηλεϊνικης ασεναπινης | |
| NO20080765L (no) | Prodrug av eksitasjonsaminosyrer | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
| ATE494890T1 (de) | Alpha-aminoamid-derivate zur behandlung von suchtstörungen | |
| EA200702109A1 (ru) | Алкинилпирролопиримидины и их применение в качестве ингибиторов hsp90 | |
| EA200700909A1 (ru) | Азаиндолкарбоксамиды | |
| EA200801343A1 (ru) | Иммуноглобулины, направленные против nogo | |
| WO2007053400A3 (en) | Piperidine glycine transporter inhibitors | |
| TW200724140A (en) | Hydantoin compounds | |
| WO2005107469A3 (en) | Morpholinyl piperidine glycine transporter inhibitors | |
| IL184355A0 (en) | Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |